Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Top Cited Papers
Open Access
- 1 February 2015
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (2), 342-362
- https://doi.org/10.1210/jc.2014-3415
Abstract
Objective: To formulate clinical practice guidelines for the pharmacological management of obesity. Participants: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the European Society of Endocrinology, and The Obesity Society reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize some of the supporting evidence. Conclusions: Weight loss is a pathway to health improvement for patients with obesity-associated risk factors and comorbidities. Medications approved for chronic weight management can be useful adjuncts to lifestyle change for patients who have been unsuccessful with diet and exercise alone. Many medications commonly prescribed for diabetes, depression, and other chronic diseases have weight effects, either to promote weight gain or produce weight loss. Knowledgeable prescribing of medications, choosing whenever possible those with favorable weight profiles, can aid in the prevention and management of obesity and thus improve health.This publication has 87 references indexed in Scilit:
- Glucagon-like peptide analogues for type 2 diabetes mellitusEmergencias, 2011
- Decision aids for people facing health treatment or screening decisionsPublished by Wiley ,2011
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutideInternational Journal of Obesity, 2011
- Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination SurveyObesity, 2010
- Cancer Incidence and Mortality After Gastric Bypass SurgeryObesity, 2009
- Molecular physiology of weight regulation in mice and humansInternational Journal of Obesity, 2008
- Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity SocietyObesity, 2008
- Central nervous system control of food intake and body weightNature, 2006
- Anatomy and regulation of the central melanocortin systemNature Neuroscience, 2005
- Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trialArthritis & Rheumatism, 2004